I am a
Home I AM A Search Login

Papers of the Week

Papers: 25 Jul 2020 - 31 Jul 2020

Animal Studies, Pharmacology/Drug Development


Front Cell Neurosci


Ceftriaxone Relieves Trigeminal Neuropathic Pain Through Suppression of Spatiotemporal Synaptic Plasticity Restoration of Glutamate Transporter 1 in the Medullary Dorsal Horn.


Luo X, He T, Wang Y, Wang J-L, Yan X-B, Zhou H-C, Wang R-R, Du R, Wang X-L, Chen J, Huang D
Front Cell Neurosci. 2020; 14:199.
PMID: 32714151.


Using a rat model of trigeminal neuropathic pain (TNP) produced by chronic compression of the infraorbital nerve (CCI-ION), we investigated the analgesic effect and the underlying mechanisms of ceftriaxone (Cef), a β-lactam antibiotic, that is thought to be a potent stimulator of glutamate transporter 1 (GLT-1). First, repeated intraperitoneal (i.p.) injections of Cef (200 mg/kg) for 5-days since Day 1 of CCI-ION could significantly relieve both mechanical and thermal pain hypersensitivity from day 10 after drug administration. Western blot and immunofluorescent results demonstrated that 5-days administration of Cef resulted in the restoration of GLT-1 expression to a level equivalent to the sham control which was dramatically lost under the TNP condition. Moreover, multi-electrode (8 × 8) array recordings of network field excitatory postsynaptic potentials (fEPSPs) were performed on the acutely dissociated medullary dorsal horn slice evoked by electrical stimulation of the trigeminal spinal tract. The results showed that the increased number of fEPSPs, induction rate, and maintenance of long-term potentiation caused by CCI-ION were significantly suppressed by 5-days administration of Cef. Taken together, the results indicate that Cef can relieve TNP through suppression of spatiotemporal synaptic plasticity GLT-1 restoration in the medullary dorsal horn of the trigeminal nerve.